Skip to main content
Log in

Synthesis, biological activity and docking study of some new isatin Schiff base derivatives

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

A set of novel Schiff bases of isatin were synthesized and characterized by reaction of isatin with various aromatic or heterocyclic primary amines. Cytotoxic activities for some of the synthesized compounds were evaluated by MTT assay in three human cancer cell lines (HeLa, LS180 and Raji). Half of the tested compounds showed good cytotoxicity in HeLa cells. 3-(2-(4-nitrophenyl) hydrazono) indolin-2-one was found to be the most potent molecule among the studied isatin derivatives. Docking studies of 3-substituted indolin-2-one scaffolds on vascular endothelial growth factor receptor 2 (VEGFR-2) involved in cell proliferation and angiogenesis was performed. 3-(naphthalen-1-ylimino) indolin-2-one and 3-(2-(4-nitrophenyl) hydrazono) indolin-2-one exhibited higher docking binding energies with receptor. For 3-(2-(4-nitrophenyl) hydrazono) indolin-2-one, H-bond interaction with Cys917 residue of target active site was in common with reported crystallographic benzoimidazole derivative (PDB code: 2OH4). New key H-bonds involving Glu915, Asn921, and Arg1049 residues in VEGFR-2 active site could be detected for 3-(2-(4-nitrophenyl) hydrazono) indolin-2-one. Extended lipophilic rings containing H-bond acceptors on the 3 position of indoline scaffold seemed to be important factors in developing potent VEGFR-2 inhibitors virtually. Based on the ligand efficiency indices, some isoxazole or thiazole substituted isatin derivatives may be regarded as efficient candidates for further molecular developments of anticancer agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Abad-Zapatero C, Metz JT (2005) Ligand efficiency indices as guideposts for drug discovery. Drug Discov Today 10(7):464–469

    Article  PubMed  Google Scholar 

  • Andrews PR, Craik DJ, Martin JL (1984) Functional group contributions to drug-receptor interactions. J Med Chem 27(12):1648–1657

    Article  PubMed  CAS  Google Scholar 

  • Azizian J, Soozangarzadeh S, Jadidi K (2001) Microwave-induced one-pot synthesis of some new spiro [3H-indole-3,5″(4″ H)-[1,2,4]-triazoline]-2-ones. Synth Commun 31(7):1069–1073

    Article  CAS  Google Scholar 

  • Azizian J, Morady AV, Soozangarzadeh S, Asadi A (2002) Synthesis of novel spiro-[3H-indole-3,3′-[1,2,4] triazolidine]-2-ones via azomethine imines. Tetrahedron Lett 43(52):9721–9723

    Article  CAS  Google Scholar 

  • Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ (2010) Virtual screening with AutoDock: theory and practice. Expert Opin Drug Discov 5(6):597–607

    Article  PubMed  CAS  Google Scholar 

  • d’Ischia M, Palumbo A, Prota G (1988) Adrenalin oxidation revisited. New products beyond the adrenochrome stage. Tetrahedron 44(20):6441–6446

    Article  Google Scholar 

  • Erickson JA, Jalaie M, Robertson DH, Lewis RA, Vieth M (2004) Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. J Med Chem 47(1):45–55

    Article  PubMed  CAS  Google Scholar 

  • Glover V, Halket JM, Watkins PJ, Clow A, Goodwin BL, Sandier M (1988) Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin. J Neurochem 51(2):656–659

    Article  PubMed  CAS  Google Scholar 

  • Hasegawa M, Nishigaki N, Washio Y, Kano K, Harris PA, Sato H, Mori I, West RI, Shibahara M, Toyoda H (2007) Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors. J Med Chem 50(18):4453–4470

    Article  PubMed  CAS  Google Scholar 

  • Hevener KE, Zhao W, Ball DM, Babaoglu K, Qi J, White SW, Lee RE (2009) Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J Chem Inf Model 49(2):444–460

    Article  PubMed  CAS  Google Scholar 

  • Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 19(10):2003–2012

    Article  PubMed  CAS  Google Scholar 

  • Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9(10):430–431

    Article  PubMed  Google Scholar 

  • Hossain MM, Islam N, Khan R, Islam M (2008) Cytotoxicity study of dimethylisatin and its heterocyclic derivatives. Bangladesh J Pharmacol 2(2):66–70

    Article  Google Scholar 

  • Iyer RA, Hanna PE (1995) N-(carbobenzyloxy) isatin: a slow binding [alpha]-keto lactam inhibitor of [alpha]-chymotrypsin. Bioorganic Med Chem Lett 5(1):89–92

    Article  CAS  Google Scholar 

  • Logan JC, Fox MP, Morgan JH, Makohon AM, Pfau CJ (1975) Arenavirus inactivation on contact with N-substituted isatin beta-thiosemicarbazones and certain cations. J Gen Virol 28(3):271

    Article  PubMed  CAS  Google Scholar 

  • Matesic L, Locke JM, Bremner JB, Pyne SG, Skropeta D, Ranson M, Vine KL (2008) N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents. Bioorganic Med Chem 16(6):3118–3124

    Article  CAS  Google Scholar 

  • Miri R, Motamedi R, Rezaei MR, Firuzi O, Javidnia A, Shafiee A (2011) Design, synthesis and evaluation of cytotoxicity of novel chromeno [4, 3-b] quinoline derivatives. Archiv der Pharmazie (Epub ahead of print)

  • Morris GM, Huey R, Olson AJ (2008) Using AutoDock for ligand-receptor docking. Curr Protoc Bioinformatics 11(3):34–37

    Google Scholar 

  • Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785–2791

    Article  PubMed  CAS  Google Scholar 

  • Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63

    Article  PubMed  CAS  Google Scholar 

  • Pandeya SN, Sriram D, Nath G, De Clercq E (1999a) Synthesis antibacterial, antifungal and anti HIV activity of Schiff’s and Mannich bases of isatin with N-[6-chlorobenz thiazole-2-yl]thiosemicarbazide. Indian J Pharm Sci 61:358–361

    Google Scholar 

  • Pandeya SN, Sriram D, Nath G, De Clercq E (1999b) Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one. Pharm Acta Helv 74(1):11–17

    Article  PubMed  CAS  Google Scholar 

  • Pandeya SN, Yogeeswari P, Sriram D, De Clercq E, Pannecouque C, Witvrouw M (1999c) Synthesis and screening for anti-HIV activity of some N-Mannich bases of isatin derivatives. Chemotherapy 45(3):192–196

    Article  PubMed  CAS  Google Scholar 

  • Pandeya SN, Sriram D, Nath G, De Clercq E (2000) Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin Mannich bases. Eur J Med Chem 35(2):249–255

    Article  PubMed  CAS  Google Scholar 

  • Pervez H, Ramzan M, Yaqub M, Mohammed Khan K (2011) Synthesis, cytotoxic and phytotoxic effects of some new N4-aryl substituted isatin-3-thiosemicarbazones. Lett Drug Des Discov 8(5):452–458

    Article  CAS  Google Scholar 

  • Phosrithong N, Ungwitayatorn J (2010) Molecular docking study on anticancer activity of plant-derived natural products. Med Chem Res 19:817–835

    Article  CAS  Google Scholar 

  • Sarangapani MR, Reddy VM (1994) Pharmacological evaluation of 1-(N,N-disubstituted aminomethyl)-3-imino-(2-phenyl-3,4-dihydro-4-oxo-quinazolin-3-yl) indolin-2-ones. Indian J Pharm Sci 56:174–177

    Google Scholar 

  • Sellers RP, Alexander LD, Johnson VA, Lin CC, Savage J, Corral R, Moss J, Slugocki TS, Singh EK, Davis MR (2010) Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives. Bioorganic Med Chem 18(18):6822–6856

    Article  CAS  Google Scholar 

  • Shuttleworth SJ, Nasturica D, Gervais C, Siddiqui MA, Rando RF, Lee N (2000) Parallel synthesis of isatin-based serine protease inhibitors. Bioorganic Med Chem Lett 10(22):2501–2504

    Article  CAS  Google Scholar 

  • Silva JFM, Garden SJ, Pinto AC (2001) The chemistry of isatins: a review from 1975 to 1999. J Brazilian Chem Soc 12(3):273–324

    Article  Google Scholar 

  • Singh SP, Shukla SK, Awasthi LP (1983) Synthesis of some 3-(4′-nitrobenzoylhydrazone)-2-indolinones as potential antiviral agents. Curr Sci 52(16):766–769

    CAS  Google Scholar 

  • Sousa SF, Fernandes PA, Ramos MJ (2006) Protein-ligand docking: current status and future challenges. Proteins 65:15–26

    Article  PubMed  CAS  Google Scholar 

  • Sridhar SK, Saravanan M, Ramesh A (2001) Synthesis and antibacterial screening of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur J Med Chem 36(7–8):615–625

    Article  PubMed  CAS  Google Scholar 

  • Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A (1996) Flk-1 as a target for tumor growth inhibition. Cancer Res 56(15):3540

    PubMed  CAS  Google Scholar 

  • Sun L, Tran N, Liang C, Tang F, Rice A, Schreck R, Waltz K, Shawver LK, McMahon G, Tang C (1999) Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl) methylidenyl] indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J Med Chem 42(25):5120–5130

    Article  PubMed  CAS  Google Scholar 

  • Varma RS, Khan IA (1977) Potential biologically active agents. X. Synthesis of 3-arylimino-2-indolinones, and their 1-methyl-and 1-morpholino/piperidinomethyl derivatives as excystment and cysticidal agents against Schizopyrenus russelli. Polish J Pharmacol Pharm 29(5):549

    CAS  Google Scholar 

  • Varma RS, Nobles WL (1967) Synthesis and antiviral and anti-bacterial activity of certain N-dialkylaminomethylisatin beta-thiosemicarbazones. J Med Chem 10:972–974

    Article  PubMed  CAS  Google Scholar 

  • Varma RS, Nobles WL (1975) Antiviral, antibacterial, and antifungal activities of isatin N Mannich bases. J Pharm Sci 64(5):881–882

    Article  PubMed  CAS  Google Scholar 

  • Vine KL, Locke JM, Ranson M, Pyne SG, Bremner JB (2007) In vitro cytotoxicity evaluation of some substituted isatin derivatives. Bioorganic Med Chem 15(2):931–938

    Article  CAS  Google Scholar 

  • Vyas V, Jain A, Gupta A (2008) Virtual screening: a fast tool for drug design. Sci Pharm 76:333–360

    Article  CAS  Google Scholar 

  • Webber SE, Tikhe J, Worland ST, Fuhrman SA, Hendrickson TF, Matthews DA, Love RA, Patick AK, Meador JW, Ferre RA (1996) Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. J Med Chem 39(26):5072–5082

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Financial supports of this project by research council of Shiraz University of Medical Sciences are acknowledged. We gratefully acknowledge the financial support from the Medicinal and Natural Products Chemistry Research Centre, Shiraz University of Medical Sciences.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ramin Miri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azizian, J., Mohammadi, M.K., Firuzi, O. et al. Synthesis, biological activity and docking study of some new isatin Schiff base derivatives. Med Chem Res 21, 3730–3740 (2012). https://doi.org/10.1007/s00044-011-9896-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-011-9896-6

Keywords

Navigation